Clinical Trial Update: Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors [NA]

View source ↗

Summary

A clinical trial evaluating oxygen-enhanced MRI to generate hypoxia maps in patients with intracranial neoplasms has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Neoplasm

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Intracranial Neoplasm | NA | Status: WITHDRAWN